Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway.
about
Clusterin: a key player in cancer chemoresistance and its inhibitionClusterin silencing inhibits proliferation and reduces invasion in human laryngeal squamous carcinoma cellsDevelopment of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasionPellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination.Lineage-specific restraint of pituitary gonadotroph cell adenoma growth.The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60.Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model.Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation.The genetics of Fuchs' corneal dystrophyCross-regulation between protein L-isoaspartyl O-methyltransferase and ERK in epithelial mesenchymal transition of MDA-MB-231 cells.Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.Targeting heat shock proteins in metastatic castration-resistant prostate cancer.Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood.Transketolase Serves a Poor Prognosticator in Esophageal Cancer by Promoting Cell Invasion via Epithelial-Mesenchymal Transition.sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo.37-kDa laminin receptor precursor promotes lung adenocarcinoma cell invasion and metastasis by epithelial-to-mesenchymal transition.Clusterin as a therapeutic target.Apocynin, an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis.Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and E-cadherin.Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells.Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer.Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells.Clusterin modulates transdifferentiation of non-small-cell lung cancer.[Mechanisms of proliferative inhibition by maimendong & qianjinweijing decoction in A549 cells].Plasticity within the niche ensures the maintenance of a Sox2+ stem cell population in the mouse incisor.Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway.Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner
P2860
Q24567925-D8D5D28C-372C-4726-852A-F603191A12F0Q33593020-FD80A718-34DF-4A7A-9268-1E9E351D503EQ33628171-E7806FCE-3D2C-479A-B774-260281690F95Q33759917-B05E6E51-1ACA-446E-A4DC-1C76E80FCE58Q33862684-9D5862D9-15BF-4686-B9A6-202D8A014C8AQ35558587-94918A12-13F8-4510-A502-CFD6D2B7FE4DQ36072803-A298E115-7CED-468F-B6B6-C38CB7A515E3Q36579884-C1FC4AD0-F4DF-475B-A173-93650525A1AEQ36754678-F7C7DF60-C0F7-4274-8560-881B580068B2Q37729814-5CF34A56-B974-4353-9892-A428031593C0Q38259980-F7F26E17-6BA1-44F6-9424-4439C0482DADQ38289945-F59A7B5C-B490-4C70-8A6B-390C3CD43634Q38298414-53098C23-762A-4A50-BAAE-CEBA8BDB8A95Q38742604-0F11466C-2F7E-42FD-B86B-141D2A695338Q38885891-00645654-A6AB-445B-8CAF-9DA0871CD506Q39005395-B87B4B73-3E4D-4C95-8AD1-7C0973E34307Q39039324-CAA1E030-400B-490B-8FA5-6EA677B7156EQ39080681-CBE26653-6E7D-45B9-A578-08D01E8D652EQ39285212-50F1122D-BE64-433D-A562-DC90FACF4B78Q39532644-734D33D9-8F07-4B18-B852-68A0BE5714CEQ39771195-81F70C71-A651-4F02-8F06-06924C3F6F77Q41887988-D79A9A06-99EE-4D08-A81E-5F1753672F54Q41996659-054318F7-D96D-40FC-B851-F220A31F8E8EQ42200953-F041DDA5-4D3E-46A4-8006-B61FCB3AD691Q42949591-C755AFED-2FDE-4BA6-9C6A-605888AC0C3FQ45941143-F15A522D-BB20-4C54-BE25-44CCA3E5CBABQ49015972-2598F8EC-0D49-4904-93EA-F76929A39793Q52894818-7C7A343F-DEB2-4FC3-9F90-670995A6971CQ53060503-B1711773-5916-46C4-9623-E6D0FDDBC499Q54270107-945FFCD4-AAC9-4373-B4F7-FB1887AA14C2Q56119780-6274E5AB-12CA-4489-A93B-D6F381D65E24
P2860
Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@ast
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@en
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@nl
type
label
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@ast
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@en
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@nl
prefLabel
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@ast
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@en
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@nl
P2093
P1433
P1476
Clusterin silencing in human l ...... dulating the ERK/Slug pathway.
@en
P2093
An-Chieh Lee
Mei-Yu Chen
Neng-Yao Shih
Su-Mei Hung
Teh-Ying Chou
Wei-Chieh Chen
P304
P356
10.1016/J.CELLSIG.2009.01.008
P577
2009-01-07T00:00:00Z